Multi-omic approaches for biomarker discovery in Moyamoya disease

Keywords

biomarkers / Moyamoya / omics

References

[1] MamiyaT, Kanamori F, YokoyamaK, et al. Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease. J Neurosurg. 2022;138(3):709-716.

[2] XuS, WeiW, ZhangF, et al. Transcriptomic profiling of intracranial arteries in adult patients with Moyamoya disease reveals novel insights into its pathogenesis. Front Mol Neurosci. 2022;15:881954.

[3] OtaS, Yokoyama K, KanamoriF, et al. Moyamoya disease specific extracellular vesicle derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing. Acta Neurochir. 2023;165(8):2045-2055.

[4] WangX, HanC, JiaY, WangJ, GeW, DuanL. Proteomic profiling of exosomes from hemorrhagic Moyamoya disease and dysfunction of mitochondria in endothelial cells. Stroke. 2021;52(10):3351-3361.

[5] WuH, XuJ, SunJ, et al. APOE as potential biomarkers of moyamoya disease. Front Neurol. 2023;14:1156894.

[6] HeS, ZhangJ, LiuZ, et al. Upregulated cytoskeletal proteins promote pathological angiogenesis in Moyamoya disease. Stroke. 2023;54(12):3153-3164.

[7] CarrozziniT, Pollaci G, GorlaG, et al. Proteome profiling of the dura mater in patients with Moyamoya angiopathy. Int J Mol Sci. 2023;24(13):11194.

[8] PollaciG, GorlaG, PotenzaA, et al. Novel multifaceted roles for RNF213 protein. Int J Mol Sci. 2022;23(9):4492.

[9] Dei CasM, Carrozzini T, PollaciG, et al. Plasma lipid profiling contributes to untangle the complexity of Moyamoya arteriopathy. Int J Mol Sci. 2021;22(24):13410.

[10] HeS, WangY, LiuZ, et al. Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin Transl Med. 2023;13(12):e1492.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.